Healthcare Services Group, Inc. (HCSG)
Healthcare
- Fundamental
- 4
- Sentiment
- 3
- Technical
- 3
Buy limit 23.15 on a retest of the rebuilt 23.00-23.15 support shelf; use a structural stop at 22.57 below the 2-session low, with 25.03 and 26.44 as ATR-based targets for a 3.24 R/R to target1.
Company overview
Healthcare Services Group, Inc. provides outsourced management and operational services to healthcare and senior living facilities across the U.S. The company offers housekeeping, laundry, facility maintenance, and dietary services to nursing homes, retirement complexes, rehabilitation centers, and hospitals. As of December 31, 2021, it served approximately 3,000 facilities nationwide.
Fundamental
goodHealthcare Services Group shows strong liquidity and profitability, though valuation concerns arise from DCF estimates below the current price.
Strong balance sheet and liquidity (net cash, current ratio ~3.02, Altman Z ~7.12) with improved profitability (TTM ROE ~24.12%) and solid cash generation (FCF yield ~9.42%). The main watch-items are customer concentration/credit-loss exposure (Genesis bankruptcy discussed in SEC filings) and the fact that DCF estimates ($14.56–$15.68/share) sit below the current price ($23.43), making valuation less of a slam dunk than simple multiples suggest. Fundamental score: 4/5.
Sentiment
fairSentiment is influenced by cybersecurity and litigation headlines, with no clear catalysts in the near term.
Near-term narrative is driven by post-Q2 earnings digestion (announced 2026-07-22) plus headlines around a ~$3M data-breach settlement (announced 2026-07-22); last ~14d media sentiment skews mildly bearish but on sparse primary-tier coverage, and the 30–90d sentiment delta is indeterminate due to insufficient relevant baseline data. No regulator-confirmed investigations surfaced (though court-record discovery was partially limited by CAPTCHA), so the overhang is more headline/cyber-risk than an acute enforcement-style event.
Technical
fairThe stock is in a corrective phase below short-term averages, favoring a pullback entry near support.
Price is still below the SMA20 and EMA9/21, but it remains above the SMA50 and SMA200 with MACD still above zero and liquidity strong, so the bullish case is a controlled support-retest trade rather than a clean momentum breakout.
You’re looking at 2026-07-29 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.